788 related articles for article (PubMed ID: 19527139)
21. [Towards a standardization of the tools for the studies of clinical proteomics].
Lucchi G; Hendra JB; Pecqueur D; Ducoroy P
Med Sci (Paris); 2007 Mar; 23 Spec No 1():19-22. PubMed ID: 17669348
[TBL] [Abstract][Full Text] [Related]
22. Urine as a source for clinical proteome analysis: from discovery to clinical application.
Rodríguez-Suárez E; Siwy J; Zürbig P; Mischak H
Biochim Biophys Acta; 2014 May; 1844(5):884-98. PubMed ID: 23831154
[TBL] [Abstract][Full Text] [Related]
23. Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application.
Lehmann S; Hoofnagle A; Hochstrasser D; Brede C; Glueckmann M; Cocho JA; Ceglarek U; Lenz C; Vialaret J; Scherl A; Hirtz C;
Clin Chem Lab Med; 2013 May; 51(5):919-35. PubMed ID: 23183755
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in proteomic technologies applied to cardiovascular disease.
Napoli C; Zullo A; Picascia A; Infante T; Mancini FP
J Cell Biochem; 2013 Jan; 114(1):7-20. PubMed ID: 22886784
[TBL] [Abstract][Full Text] [Related]
25. [Research progress of body fluid proteomics in diagnosis of tuberculosis].
Zhang X; Zhang ZD; Li Q
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):207-9. PubMed ID: 23856145
[No Abstract] [Full Text] [Related]
26. ["Standard" protocol for evaluating the impact of preanalytical variables on peptidic and proteic analytes and standard coding of preanalytical procedures].
Betsou F; Beaudeux JL; Berthelaix A; Borg J; Dupuy A; Lizard G; Peoc'h K; Quillard M; Lehmann S
Ann Biol Clin (Paris); 2009; 67(6):641-9. PubMed ID: 19939767
[TBL] [Abstract][Full Text] [Related]
27. Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics.
Rai AJ; Vitzthum F
Expert Rev Proteomics; 2006 Aug; 3(4):409-26. PubMed ID: 16901200
[TBL] [Abstract][Full Text] [Related]
28. Biological sample collection for clinical proteomics: existing SOPs.
Lygirou V; Makridakis M; Vlahou A
Methods Mol Biol; 2015; 1243():3-27. PubMed ID: 25384737
[TBL] [Abstract][Full Text] [Related]
29. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
Calvo KR; Liotta LA; Petricoin EF
Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
[TBL] [Abstract][Full Text] [Related]
30. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
31. MS-Based Proteomics of Body Fluids: The End of the Beginning.
Bader JM; Albrecht V; Mann M
Mol Cell Proteomics; 2023 Jul; 22(7):100577. PubMed ID: 37209816
[TBL] [Abstract][Full Text] [Related]
32. Value of proteomics applied to the follow-up in stem cell transplantation.
Weissinger EM; Mischak H; Ganser A; Hertenstein B
Ann Hematol; 2006 Apr; 85(4):205-11. PubMed ID: 16463156
[TBL] [Abstract][Full Text] [Related]
33. Peptide mapping of proteins in human body fluids using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
Bergquist J; Palmblad M; Wetterhall M; Håkansson P; Markides KE
Mass Spectrom Rev; 2002; 21(1):2-15. PubMed ID: 12210611
[TBL] [Abstract][Full Text] [Related]
34. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C
J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598
[TBL] [Abstract][Full Text] [Related]
35. [Present possibilities and future development of clinical proteomics].
Lehmann S; Dupuy A; Peoc'h K; Roche S; Baudin B; Quillard M; Berger F; Briand G; Chwetzoff S; Dine G; Gonzalo P; Dastugue B; Sève M; Siest G; Beaudeux JL
Ann Biol Clin (Paris); 2007; 65(5):463-71. PubMed ID: 17913666
[TBL] [Abstract][Full Text] [Related]
36. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.
Yasui Y; Pepe M; Thompson ML; Adam BL; Wright GL; Qu Y; Potter JD; Winget M; Thornquist M; Feng Z
Biostatistics; 2003 Jul; 4(3):449-63. PubMed ID: 12925511
[TBL] [Abstract][Full Text] [Related]
37. Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine.
Terracciano R; Pasqua L; Casadonte F; Frascà S; Preianò M; Falcone D; Savino R
Bioconjug Chem; 2009 May; 20(5):913-23. PubMed ID: 19338374
[TBL] [Abstract][Full Text] [Related]
38. High-accuracy proteome maps of human body fluids.
Schmidt A; Aebersold R
Genome Biol; 2006; 7(11):242. PubMed ID: 17140426
[TBL] [Abstract][Full Text] [Related]
39. Direct Assessment of Plasma/Serum Sample Quality for Proteomics Biomarker Investigation.
Greco V; Piras C; Pieroni L; Urbani A
Methods Mol Biol; 2017; 1619():3-21. PubMed ID: 28674873
[TBL] [Abstract][Full Text] [Related]
40. Biomarker discovery and applications for foods and beverages: proteomics to nanoproteomics.
Agrawal GK; Timperio AM; Zolla L; Bansal V; Shukla R; Rakwal R
J Proteomics; 2013 Nov; 93():74-92. PubMed ID: 23619387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
